Signaturefd, LLC Gritstone Bio, Inc. Transaction History

Signaturefd, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.77 - $4.34 $1,552 - $3,806	-877 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$4.03 - $12.19 $3,195 - $9,666	793 Added 944.05%	877 $4,000
Q4 2021 Jan 25, 2022	BUY	$8.76 - $13.71 $140 - $219	16 Added 23.53%	84 $1,000
Q3 2021 Oct 28, 2021	SELL	$6.41 - $13.54 $70 - $148	-11 Reduced 13.92%	68 $1,000
Q2 2021 Jul 26, 2021	BUY	$8.13 - $10.2 $642 - $805	79 New	79 $1,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.